Johnson & Johnson Slides On Top-Line Miss, Disappointing Drug Sales, Soft Outlook
January 24, 2017 at 07:46 AM EST
Johnson & Johnson reported strong earnings, with EPS of $1.58 coming stronger than the $1.56 consensus expectation, despite revenue of $1.81BN missing consensus of $18.28BN.
